AG
CNMD icon

Algert Global’s CONMED CNMD Stock Holding History

Algert Global’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.3M Buy
131,293
+47,293
+56% +$1.7M 0.05% 596
2026
Q1 		$2.97M Buy
84,000
+42,500
+102% +$1.73M 0.04% 600
2025
Q4 		$1.68M Buy
41,500
+12,330
+42% +$536K 0.03% 751
2025
Q3 		$1.37M Buy
+29,170
New +$1.51M 0.02% 780
2024
Q3 		– Sell
-14,523
Closed -$1.01M – 1251
2024
Q2 		$1.01M Sell
14,523
-27,027
-65% -$1.97M 0.03% 682
2024
Q1 		$3.33M Buy
+41,550
New +$3.7M 0.13% 264

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Algert Global's CNMD Position: Q2 2026 in Review

Algert Global increased its CONMED (CNMD) stake by 56% in Q2 2026, buying an estimated $1.7M and bringing the position to 131,293 shares worth $4.3M. The position accounts for 0.05% of the portfolio, ranked #596.

Algert Global first reported a position in CNMD in Q1 2024 and has held it in 6 quarters since. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Algert Global held 131,293 shares of CONMED worth $4.3M as of Q2 2026.
  • Algert Global bought 47,293 CONMED shares in Q2 2026, an estimated $1.7M.
  • CONMED made up 0.05% of Algert Global's portfolio in Q2 2026, its #596 holding.
  • Algert Global first reported a position in CONMED in Q1 2024 and has held it in 6 quarters since.
  • 247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.